Blood Lead Level as Marker of Increased Risk of Ovarian Cancer in BRCA1 Carriers

- Kiljańczyk, Adam, Matuszczak, Milena, Gronwald, Jacek, Huzarski, Tomasz, Lener, Marcin R., Jakubowska, Anna, Szwiec, Marek, Stawicka-Niełacna, Malgorzata, Godlewski, Dariusz, Prusaczyk, Artur, Jasiewicz, Andrzej, Kluz, Tomasz, Marciniak, Wojciech, Tomiczek-Szwiec, Joanna, Kilar-Kobierzycka, E, Siołek, M, Wiśniowski, R, Posmyk, R, Jarkiewicz-Tretyn, J, Sun, P, Scott, Rodney J., Narod, SA, Lubiński, J, Derkacz, Róża, Stempa, Klaudia, Baszuk, Piotr, Bryśkiewicz, Marta, Lubiński, Krzysztof, Cybulski, Cezary, Dębniak, Tadeusz

Zinc and Its Antioxidant Properties: The Potential Use of Blood Zinc Levels as a Marker of Cancer Risk in BRCA1 Mutation Carriers

- Matuszczak, Milena, Kiljańczyk, Adam, Dębniak, Tadeusz, Gronwald, Jacek, Huzarski, Tomasz, Lener, Marcin R., Jakubowska, Anna, Szwiec, Marek, Stawicka-Niełacna, Malgorzata, Godlewski, Dariusz, Prusaczyk, Artur, Jasiewicz, Andrzej, Marciniak, Wojciech, Kluz, Tomasz, Tomiczek-Szwiec, J, Kilar-Kobierzycka, E, Siołek, M, Wiśniowski, R, Posmyk, R, Jarkiewicz-Tretyn, J, Scott, Rodney J., Narod, SA, Lubiński, J, Derkacz, Róża, Stempa, Klaudia, Baszuk, Piotr, Bryśkiewicz, Marta, Sun, Ping, Cheriyan, Angela, Cybulski, Cezary

Extracellular matrix in high-grade serous ovarian cancer: Advances in understanding of carcinogenesis and cancer biology

- Brown, Yazmin, Hua, Susan, Tanwar, Pradeep S.

Molecular analysis of early-stage ovarian cancer

- Venkata, Varshini Devarapalli

Pathways to diagnosis of endometrial and ovarian cancer in the 45 and Up Study cohort

- Yap, Sarsha, Vassallo, Amy, Goldsbury, David, O'Connell, Dianne L., Brand, Alison, Emery, Jon, DeFazio, Anna, Canfell, Karen, Steinberg, Julia

Sequential azacitidine and carboplatin induces immune activation in platinum-resistant high-grade serous ovarian cancer cell lines and primes for checkpoint inhibitor immunotherapy

- Wong-Brown, Michelle W., van der Westhuizen, Andre, Bowden, Nikola A.

Targeting Homologous Recombination Deficiency in Ovarian Cancer with PARP Inhibitors: Synthetic Lethal Strategies That Impact Overall Survival

- Xie, Tao, Dickson, Kristie-Ann, Yee, Christine, Ma, Yue, Ford, Caroline E., Bowden, Nikola A., Marsh, Deborah J.

Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers

- Glubb, Dylan M., Thompson, Deborah J., Bermisheva, Marina, McNeish, IA, Menon, U, Modugno, F, Moysich, KB, Nevanlinna, H, Odunsi, K, Olsson, H, Orsulic, S, Osorio, A, Palli, D, Bernardini, Marcus Q., Park-Simon, T-W, Pearce, CL, Pejovic, T, Permuth, JB, Podgorska, A, Ramus, SJ, Rebbeck, TR, Riggan, MJ, Risch, HA, Rothstein, JH, Bischof, Katharina, Runnebaum, IB, Scott, RJ, Sellers, TA, Senz, J, Setiawan, VW, Siddiqui, N, Sieh, W, Spiewankiewicz, B, Sutphen, R, Swerdlow, AJ, Bjorge, Line, Szafron, LM, Teo, SH, Thompson, PJ, Thomsen, LCV, Titus, L, Tone, A, Tumino, R, Turman, C, Vanderstichele, A, Edwards, DV, Bodelon, Clara, Vergote, I, Vierkant, RA, Wang, Z, Wang-Gohrke, S, Webb, PM, White, E, Whittemore, AS, Winham, SJ, Wu, X, Wu, AH, Brand, Alison H., Yannoukakos, D, Spurdle, AB, O'Mara, TA, Brenton, James D., Brinton, Louise A., Bruinsma, Fiona, Buchanan, Daniel D., Aben, Katja K. H., Burghaus, S, Butzow, R, Cai, H, Carney, ME, Chanock, SJ, Chen, C, Chen, XQ, Chen, Z, Cook, LS, Cunningham, JM, Alsulimani, Ahmad, De Vivo, I, DeFazio, A, Doherty, JA, Dork, T, du Bois, A, Dunning, AM, Durst, M, Edwards, T, Edwards, RP, Ekici, AB, Amant, Frederic, Ewing, A, Fasching, PA, Ferguson, S, Flanagan, JM, Fostira, F, Fountzilas, G, Friedenreich, CM, Gao, B, Gaudet, MM, Gawelko, J, Annibali, Daniela, Gentry-Maharaj, A, Giles, GG, Glasspool, R, Goodman, MT, Gronwald, J, Harris, HR, Harter, P, Hein, A, Heitz, F, Hildebrandt, MAT, Attia, John, Hillemanns, P, Hogdall, E, Hogdall, CK, Holliday, Elizabeth G., Huntsman, DG, Huzarski, T, Jakubowska, A, Jensen, A, Jones, ME, Karlan, BY, Barricarte, Aurelio, Karnezis, A, Kelley, JL, Khusnutdinova, E, Killeen, JL, Kjaer, SK, Klapdor, R, Kobel, M, Konopka, B, Konstantopoulou, I, Kopperud, RK, Beckmann, Matthias W., Koti, M, Kraft, P, Kupryjanczyk, J, Lambrechts, D, Larson, MC, Le Marchand, L, Lele, S, Lester, J, Li, AJ, Liang, D, Berchuck, Andrew, Liebrich, C, Lipworth, L, Lissowska, J, Lu, L, Lu, KH, Macciotta, A, Mattiello, A, May, T, McAlpine, JN, McGuire, V

Early serous ovarian carcinogenesis: understanding the genetic and lifestyle factors

- Bangaraswamaiah Nagendra, Prathima

In Vivo cell fate tracing provides no evidence for mesenchymal to epithelial transition in adult fallopian tube and uterus

- Ghosh, Arnab, Syed, Shafiq M., Kumar, Manish, Carpenter, Tyler J., Teixeira, Jose M., Houairia, Nathaniel, Negi, Sumedha, Tanwar, Pradeep S.

Targeted sequencing of genes associated with the mismatch repair pathway in patients with endometrial cancer

- Singh, Ashish Kimar, Talseth-Palmer, Bente, McPhillips, Mary, Lavik, Liss Anne Solberg, Xavier, Alexandre, Drablos, Finn, Sjursen, Wenche

Targeting DNA repair in ovarian cancer treatment resistance

- Wong-Brown, M. W., van der Westhuizen, A., Bowden, N. A.

Genesis of ovarian cancer: understanding the mechanisms of oviductal epithelial cell homoeostasis

- Ghosh, Arnab

Investigating the role of microenvironment and matrix stiffness in ovarian cancer development

- Adebayo, Mariam Folashade

The preventable burden of endometrial and ovarian cancers in Australia: a pooled cohort study

- Laaksonen, Maarit A., Arriaga, Maria E., Canfell, Karen, MacInnis, Robert J., Byles, Julie E., Banks, Emily, Shaw, Jonathan E., Mitchell, Paul, Giles, Graham G., Magliano, Dianna J., Gill, Tiffany K., Klaes, Elizabeth, Velentzis, Louiza S., Hirani, Vasant, Cumming, Robert G., Vajdic, Claire M.

Age-related mTOR in ovarian and endometrial cancers

- Bajwa, Preety

Biomarkers of platinum resistance in ovarian cancer: What can we use to improve treatment

- Van Zyl, Belinda, Tang, Denise, Bowden, Nikola A.

Nucleotide excision repair protein ERCC1 and tumour-infiltrating lymphocytes are potential biomarkers of neoadjuvant platinum resistance in high grade serous ovarian cancer

- Scurry, James, van Zyl, Belinda, Gulliver, Damien, Otton, Geoffrey, Jaaback, Kenneth, Lombard, Janine, Vilain, Ricardo E., Bowden, Nicola A.

The nerve-cancer connection in ovarian cancer

- Rodrigues Oliveira, Sónia Marlene

In vivo genetic cell lineage tracing reveals that oviductal secretory cells self-renew and give rise to ciliated cells

- Ghosh, Arnab, Syed, Shafiq M., Tanwar, Pradeep S.